IMMUNODIFFUSION TEST HUMAN ANTITHROMBIN— 510(k) K831961

Name: FDA 510(k) clearance K831961
Creator: U.S. Food and Drug Administration
Published: 1983-08-11

Substantially Equivalent

Kent Laboratories, Inc.

FDA 510(k) clearance K831961 for IMMUNODIFFUSION TEST HUMAN ANTITHROMBIN, Substantially Equivalent on 1983-08-11. Applicant: Kent Laboratories, Inc.. Device class: 2.

Clearance details

Applicant: Kent Laboratories, Inc.
Product code: Code JBQ
Device class: Class 2
Regulation: 21 CFR 864.7060
Advisory panel: Hematology
Date received: 1983-06-17
Decision date: 1983-08-11
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mchenry, IL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JBQ

view all

K242952 — INNOVANCE Antithrombin2025-03-28
K081769 — INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO52009-05-28
K070301 — HEMOSIL ANTITHROMBIN2007-02-23
K062431 — HEMOSIL LIQUID ANTITHROMBIN2006-09-01
K043007 — BIOPHEN ANTITHROMBIN 2.5, REFERENCE # 221102; BIOPHEN ANTITHROMBIN 5, REFERENCE # 2211052005-11-07

More clearances from Kent Laboratories, Inc.

view all

K951966 — HUMAN PREALBUMIN RADIAL IMMUNODIFFUSION KIT1995-06-01
K951967 — HUMAN C1 INACTIVATOR OR C-1 ESTERASE INHIBITOR RADIAL IMMUNODIFFUSION KIT1995-05-30
K951968 — HUMAN C1Q RADIAL IMMUNODIFFUSION KIT1995-05-30
K950102 — HUMAN C-5 RADIAL IMMUNODIFFUSION KIT1995-04-10
K850683 — 72 DETERM. SIZE RADIAL IMMUNODIFFUSION TEST ALPHA21985-11-27

Data sourced from openFDA. This site is unofficial and independent of the FDA.